日水製薬(株)の貸借残高情報
| 主市場 | 業種 | 証券コード/EDINET | 英名称 |
|---|---|---|---|
| 東証PRM | 医薬品 | 4550/E00971 | Nissui Pharmaceutical Co., Ltd |
| 公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
|---|---|---|---|---|---|---|---|---|---|
| 2016/06/10 | 日証協 | 20,290株 | -0.49% | 37,800株 | -49.06% | 100,559株 | -2.9% | 2,700株 | -54.24% |
| 2016/06/03 | 日証協 | 20,390株 | +29.13% | 74,200株 | +43.52% | 103,559株 | +2.98% | 5,900株 | +436.36% |
| 2016/05/27 | 日証協 | 15,790株 | +33.93% | 51,700株 | +515.48% | 100,560株 | 0% | 1,100株 | -86.25% |
| 2016/05/20 | 日証協 | 11,790株 | +38.87% | 8,400株 | +110% | 100,560株 | +3.38% | 8,000株 | +115.63% |
| 2016/05/13 | 日証協 | 8,490株 | +21.46% | 4,000株 | 0% | 97,270株 | +2.97% | 3,710株 | +85.5% |
| 2016/05/06 | 日証協 | 6,990株 | 0% | 0株 | 0% | 94,460株 | +0.64% | 2,000株 | +42.86% |
| 2016/04/28 | 日証協 | 6,990株 | -6.68% | 0株 | -100% | 93,860株 | +0.21% | 1,400株 | +27.27% |
| 2016/04/22 | 日証協 | 7,490株 | +8.55% | 1,290株 | -43.91% | 93,660株 | -0.21% | 1,100株 | -60.73% |
| 2016/04/15 | 日証協 | 6,900株 | +23.43% | 2,300株 | -11.54% | 93,860株 | +2.29% | 2,801株 | -91.83% |
| 2016/04/08 | 日証協 | 5,590株 | -3.45% | 2,600株 | -78.49% | 91,759株 | +59.7% | 34,300株 | -41.62% |
| 2016/04/01 | 日証協 | 5,790株 | -47.36% | 12,090株 | +168.67% | 57,457株 | -5.28% | 58,757株 | +80.79% |
| 2016/03/25 | 日証協 | 11,000株 | -0.9% | 4,500株 | +246.15% | 60,659株 | -10.35% | 32,500株 | +1254.17% |
| 2016/03/18 | 日証協 | 11,100株 | +7.45% | 1,300株 | -35% | 67,659株 | -1.74% | 2,400株 | -40.13% |
| 2016/03/11 | 日証協 | 10,330株 | +22.54% | 2,000株 | -45.95% | 68,859株 | +4.25% | 4,009株 | -10.91% |
| 2016/03/04 | 日証協 | 8,430株 | -14.24% | 3,700株 | +46.25% | 66,050株 | +1.07% | 4,500株 | +2.97% |
| 2016/02/26 | 日証協 | 9,830株 | +5.7% | 2,530株 | -60.47% | 65,350株 | -1.66% | 4,370株 | +1.63% |
| 2016/02/19 | 日証協 | 9,300株 | +52.46% | 6,400株 | 0% | 66,450株 | +2.43% | 4,300株 | +38.71% |
| 2016/02/12 | 日証協 | 6,100株 | -12.86% | 0株 | -100% | 64,874株 | -6.76% | 3,100株 | -3.12% |
| 2016/02/05 | 日証協 | 7,000株 | +32.08% | 800株 | -38.46% | 69,575株 | +1.9% | 3,200株 | +146.15% |
※株式分割は考慮していませんのでご注意ください。